A blood test that uses artificial intelligence (AI) to detect cancer-related genetic changes and protein biomarkers could help screen women for early signs of ovarian cancer, according to a study by researchers at the Johns Hopkins Kimmel Cancer Center in collaboration with several other institutions in the United States and Europe.
AI ‘liquid biopsies’ using cell-free DNA, protein biomarkers, could aid early detection of ovarian cancer
